Biotech firm Ascletis Pharma said ASC47, its muscle-preserving weight loss drug candidate, could boost the efficacy of the ...

The new tariffs, effective 1 October, are also aimed at kitchen cabinets, bathroom vanities & heavy trucks. Any levies on ...

Experts in Europe are concerned about what the global GLP-1 agonist excitement could mean for childhood obesity, which can ...

Pfizer said on Monday it would acquire drug developer Metsera in a deal valued at up to $7.3 billion, including future ...

Researchers in Denmark observed a significant drop-off in anti-obesity drug usage after 1 year in first-time users.

An IQVIA report published earlier this year found that 43% of anti-obesity assets currently in development are orally ...

Among 77,310 adults without diabetes who began taking semaglutide after it was approved for weight loss, 40,262 (52%) were no ...

Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% ...

Weight management drugs like the GLP-1 can significantly improve health outcomes, but their exorbitant prices often limit ...

UK shoppers are the most budget-conscious in the world when it comes to wellness, says Alex Heffernan, insight manager for ...

"The findings are very exciting,” said Dr. Prachi Singh at Pennington Biomedical. “This supports the growing understanding ...

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at ...